NovoCure (NVCR) Treasury Shares (2017 - 2026)

NovoCure's Treasury Shares history runs 10 years deep, the most recent figure standing at $12.6 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 9.21% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $12.6 million (down 9.21% YoY), while the FY2025 annual figure was $13.1 million, up 8.85% from the prior year.
• Treasury Shares came in at $12.6 million for Q1 2026 at NovoCure, down from $13.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $13.9 million in Q1 2025 to a low of $5.0 million in Q1 2022.
• A 5-year average of $9.6 million and a median of $12.1 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 142.87% in 2024 and decreased 9.21% in 2026, its largest moves.
• NovoCure's Treasury Shares stood at $5.4 million in 2022, then grew by 8.1% to $5.8 million in 2023, then surged by 107.58% to $12.1 million in 2024, then rose by 8.85% to $13.1 million in 2025, then declined by 3.86% to $12.6 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $12.6 million, $13.1 million, and $13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison